The recalled ibuprofen tablets may contain individual blistered doses labeled as oxcarbazepine tablets. AHP also recalled the oxcarbazepine tablets due to a mislabeled blister packaging which could result in patients receiving ibuprofen instead.
If a patient misses a dose of oxcarbazepine, used to treat certain type of epileptic seizures, the risk for a seizure increases. Additionally, if a patient accidently consumes ibuprofen, it may cause adverse reactions, according to the U.S. Food and Drug Administration notification regarding the recall.
More Articles on Recalls:
Baxter Initiates Worldwide Saline Solution Recall
5 Health IT Safety Issues Hospital Executives Should Monitor
OR Implants and the Case for Supply Chain Automation
